HCV

The Final Push to Eliminate Viral Hepatitis


Multiple authors

European Association for the Study of the Liver | EASL
ACHIEVE Coalition
MEP Friends of the Liver Group
European Centre for Disease Prevention and Control | ECDC
European Cancer Organisation | ECO
Directorate-General for Health and Food Safety | DG SANTE
03.10.2022

The final push to eliminate viral hepatitis – how can the EU lead the successful achievement of this global public health priority?

This high-level conference is hosted by MEP Friends of the Liver Group with the support of EASL (European Association for the Study of the Liver) and ACHIEVE (Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe).

The conference will include a panel discussion including representatives from the European Commission’s DG SANTEEuropean Centre for Disease Prevention and Control (ECDC), European Cancer Organisation (ECO).

“In June 2022, WHO approved the Global Health Strategy Against Viral Hepatitis (2022-2030) which reaffirms the 2030 elimination target. However, progress in some Member States is lagging and mortality from hepatitis-related liver cancer is on the rise. The situation is even worse in some other World Regions.”

Kicked off by interventions by ACHIEVE and EASL, we would thus like to explore with our panelists and the audience:

  • What can the EU do to lead and achieve this global public health goal?
  • How can Europe’s Beating Cancer Plan support this aim?
  • Which are the funding needs from EU4Health for the years to come, and how can it be ensured that Member States and regions in greatest need will profit from this funding?
  • How can good practices be shared and picked up?
Table of contents